U.S. Semiconductors Stock News

Unisys stock's consensus analyst price target has recently dropped from $7.67 to $6.75, marking a notable shift in sentiment. While revenues remain stable and new business wins point toward growth, analysts appear divided over the pace and reliability of further progress. Stay tuned to find out how these evolving developments might reshape the outlook and how you can keep track of the ongoing shifts in the Unisys story. What Wall Street Has Been Saying Analyst sentiment on Unisys stock...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

AMFI (OTCPK:AFIP.A) may not always grab headlines, but its recent moves in the market have investors wondering what the next chapter might hold. There’s no major headline event or explosive news to explain recent activity, and that in itself brings an intriguing question: is the current share price momentum sending a subtle signal, or is it simply business as usual for a company flying under the radar? Looking at the past few months, AMFI’s share price hasn’t budged—flat over the past week...

Guardant Health's consensus analyst price target saw only a slight increase in the most recent update, moving from $61.33 to $62.41. This relatively stable price expectation reflects strong revenue momentum and continued leadership in liquid biopsy technology. It also shows tempered optimism following recent clinical data results. Read on to discover what is driving these perspectives and how you can stay informed about evolving developments for Guardant Health moving forward. What Wall...

Avadel Pharmaceuticals recently saw its consensus analyst price target edge up slightly from $20.20 to $20.30, reflecting a largely steady outlook. This minimal change is rooted in a balance between optimism over Lumryz’s commercial momentum and lingering concerns about ongoing competition in the sleep disorder market. Read on to discover how you can stay informed about ongoing shifts in the stock's narrative as new developments unfold. What Wall Street Has Been Saying Analyst commentary on...

Cellebrite DI's consensus analyst price target has seen a modest uptick, rising from $22.57 to $23.14 despite several headwinds. While lingering softness in the U.S. federal market and revised revenue estimates have tempered enthusiasm, analysts attribute much of this to deal timing delays rather than a loss of demand. Stay tuned to find out how you can track ongoing developments in Cellebrite DI's evolving story. What Wall Street Has Been Saying Analyst coverage of Cellebrite DI reflects a...

When researching a stock for investment, what can tell us that the company is in decline? Typically, we'll see the...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

As the U.S. stock market experiences a downturn led by declines in tech shares, small-cap stocks present an intriguing opportunity for investors navigating the current economic landscape shaped by recent Federal Reserve rate cuts. In this environment, identifying small-cap companies with strong fundamentals and insider buying can be key to uncovering potential value amidst broader market fluctuations.

In September 2025, U.S. stock markets have experienced a downturn, with major indices like the Dow Jones Industrial Average, S&P 500, and Nasdaq all closing lower due to declines in tech shares following Federal Reserve Chair Jerome Powell's comments on interest rates. Amidst this backdrop of fluctuating market conditions and high valuations, growth companies with significant insider ownership can offer a unique perspective on potential resilience and strategic direction in uncertain times.

As of late September 2025, the U.S. stock market has experienced a downturn, with major indices such as the Dow Jones Industrial Average, S&P 500, and Nasdaq closing lower due to declines in tech stocks following comments from Federal Reserve Chair Jerome Powell. Amidst these broader market movements, investors often look for opportunities that offer potential growth at lower price points. Penny stocks—though an older term—still represent a compelling investment area by highlighting smaller...

We feel now is a pretty good time to analyse Inspira Technologies Oxy B.H.N. Ltd.'s ( NASDAQ:IINN ) business as it...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company...

A number of Rhinebeck Bancorp, Inc. ( NASDAQ:RBKB ) insiders sold their shares in the last year, which may have raised...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

DoubleVerify Holdings, Inc. ( NYSE:DV ) shareholders won't be pleased to see that the share price has had a very rough...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Credo Technology Group Holding Ltd ( NASDAQ:CRDO ) shares have continued their recent momentum with a 42% gain in the...

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...

Most readers would already be aware that Hamilton Insurance Group's (NYSE:HG) stock increased significantly by 17% over...

PVH's (NYSE:PVH) stock is up by a considerable 38% over the past three months. As most would know, fundamentals are...

The Boston Beer Company, Inc. ( NYSE:SAM ), might not be a large cap stock, but it saw a decent share price growth of...